Elanco Animal Health (ELAN) Other Non-Current Assets (2017 - 2026)
Elanco Animal Health's (ELAN) quarterly Other Non-Current Assets came in at $304.0 million in Q2 2026, down 1.3% year-over-year from $308.0 million in Q2 2025, and up 3.05% quarter-over-quarter from $295.0 million in Q1 2026.
Analysis
Elanco Animal Health (ELAN) Other Non-Current Assets (2017 - 2026) Analysis & Trends
Elanco Animal Health has disclosed Other Non-Current Assets across 10 years of filings, most recently posting $304.0 million for Q2 2026.
- In Q2 2026, Other Non-Current Assets fell 1.3% year-over-year to $304.0 million; the TTM figure through Jun 2026 stood at $304.0 million (down 1.3% YoY), while the FY2025 annual figure was $304.0 million, down 2.25% from the prior year.
- Other Non-Current Assets came in at $304.0 million for Q2 2026 at Elanco Animal Health, up from $295.0 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $651.0 million in Q1 2024 to a low of $295.0 million in Q1 2026.
- Average Other Non-Current Assets over 5 years is $386.0 million, with a median of $355.0 million recorded in 2023.
- Year-over-year, Other Non-Current Assets surged 76.42% in 2024 and plunged 52.07% in 2025.
- Over 5 years, Other Non-Current Assets stood at $378.0 million in 2022, then decreased by 9.79% to $341.0 million in 2023, then slipped by 8.8% to $311.0 million in 2024, then declined by 2.25% to $304.0 million in 2025, then changed by 0.0% to $304.0 million in 2026.
- Per Business Quant data, the three most recent Other Non-Current Assets figures were $304.0 million in Q2 2026, $295.0 million in Q1 2026, and $304.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.53 Bn | 40.34 Bn | 779.09 Mn | 567.73 Mn |
| 2 | Zoetis | 30.65 Bn | 28.97 Bn | 1.05 Bn | 384.00 Mn |
| 3 | Elanco Animal Health | 11.81 Bn | 11.28 Bn | 798.00 Mn | 304.00 Mn |
| 4 | Phibro Animal Health | 1.51 Bn | 1.42 Bn | 134.40 Mn | 106.46 Mn |
| 5 | Immucell | 89.92 Mn | 81.06 Mn | 2.44 Mn | 31,658.00 |
| 6 | Zhengye Biotechnology Holding | 76.23 Mn | 69.14 Mn | - | 988,922.10 |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 304.00 Mn |
| Mar 31, 2026 | 295.00 Mn |
| Dec 31, 2025 | 304.00 Mn |
| Sep 30, 2025 | 306.00 Mn |
| Jun 30, 2025 | 308.00 Mn |
| Mar 31, 2025 | 312.00 Mn |
| Dec 31, 2024 | 311.00 Mn |
| Sep 30, 2024 | 302.00 Mn |
| Jun 30, 2024 | 627.00 Mn |
| Mar 31, 2024 | 651.00 Mn |
| Dec 31, 2023 | 341.00 Mn |
| Sep 30, 2023 | 410.00 Mn |
| Jun 30, 2023 | 419.00 Mn |
| Mar 31, 2023 | 369.00 Mn |
| Dec 31, 2022 | 378.00 Mn |
| Sep 30, 2022 | 376.00 Mn |
| Jun 30, 2022 | 376.00 Mn |
| Mar 31, 2022 | 559.00 Mn |
| Dec 31, 2021 | 390.00 Mn |
| Sep 30, 2021 | 357.00 Mn |